Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2020 at "Cancer Medicine"
DOI: 10.1002/cam4.3242
Abstract: Nearly 80% of advanced cancer patients are afflicted with cachexia, a debilitating syndrome characterized by extensive loss of muscle mass and function. Cachectic cancer patients have a reduced tolerance to antineoplastic therapies and often succumb…
read more here.
Keywords:
muscle;
bard1;
breast cancer;
model ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2020 at "Nature Communications"
DOI: 10.1038/s41467-020-18838-2
Abstract: p50, the mature product of NFKB1, is constitutively produced from its precursor, p105. Here, we identify BARD1 as a p50-interacting factor. p50 directly associates with the BARD1 BRCT domains via a C-terminal phospho-serine motif. This…
read more here.
Keywords:
mono ubiquitination;
p50;
bard1;
cell cycle ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Scientific Reports"
DOI: 10.1038/s41598-017-07962-7
Abstract: The present study was designed to investigate the potential clinical, pathological, prognostic value, role and mechanism of BRCA1-associated RING Domain 1 (BARD1) in Hepatocellular carcinoma (HCC). Quantitative real-time PCR and immunohistochemistry were performed to evaluate…
read more here.
Keywords:
associated ring;
hcc;
bard1;
ring domain ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2019 at "Cold Spring Harbor Molecular Case Studies"
DOI: 10.1101/mcs.a004093
Abstract: Germline pathogenic variants in BRCA1/2 account for one-third of familial breast cancers. The majority of BRCA1 function requires heterodimerization with BARD1. In contrast to BRCA1, BARD1 is a low-penetrance gene with an unclear clinical relevance,…
read more here.
Keywords:
pathogenic variants;
bard1;
breast cancers;
germline ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-6001
Abstract: Introduction: Vascular endothelial growth factor (VEGF) is a key promoter of angiogenesis and disease progression in epithelial ovarian cancer (OC). Bevacizumab, a humanized anti-VEGF monoclonal antibody, is approved for treatment of patients with ovarian and…
read more here.
Keywords:
ava therapy;
anti vegf;
therapy;
bard1 ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Cancers"
DOI: 10.3390/cancers11060740
Abstract: In addition to several well-established breast cancer (BC) susceptibility genes, the contribution of other candidate genes to BC risk remains mostly undefined. BARD1 is a potentially predisposing BC gene, however, the rarity of its mutations…
read more here.
Keywords:
risk;
bard1;
study;
association ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Cancers"
DOI: 10.3390/cancers14071848
Abstract: Simple Summary RNA binding proteins (RBPs) post-transcriptionally regulate and stabilize a variety of target mRNA transcripts. Human Antigen R (HuR) binds to several pro-survival mRNA transcripts and promotes tumor cell survival and chemotherapeutic resistance. Some…
read more here.
Keywords:
pdac;
associated ring;
hur;
ring domain ... See more keywords
Photo from academic.microsoft.com
Sign Up to like & get
recommendations!
1
Published in 2021 at "Genes"
DOI: 10.3390/genes12020320
Abstract: Melanoma comprises
read more here.
Keywords:
expression bard1;
splice;
bard1 isoforms;
differential expression ... See more keywords